» Authors » Lila J Finney Rutten

Lila J Finney Rutten

Explore the profile of Lila J Finney Rutten including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 179
Citations 4035
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
31.
Greenberg-Worisek A, Kurani S, Finney Rutten L, Blake K, Moser R, Hesse B
J Med Internet Res . 2022 May; 24(5):e39712. PMID: 35617681
[This corrects the article DOI: 10.2196/13300.].
32.
Zhu X, Weiser E, Jacobson D, Griffin J, Limburg P, Finney Rutten L
Prev Chronic Dis . 2022 Apr; 19:E19. PMID: 35420980
Introduction: Colorectal cancer (CRC) screening among average-risk patients is underused in the US. Clinician recommendation is strongly associated with CRC screening completion. To inform interventions that improve CRC screening uptake...
33.
Phelan S, Bauer K, Bradley D, Bradley S, Haller I, Mundi M, et al.
Obes Sci Pract . 2022 Apr; 8(2):139-146. PMID: 35388341
Objective: Obesity is stigmatized and people with obesity report experiencing stigmatizing situations when seeking health care. The implications of these experiences are not well understood. This study tests an indirect...
34.
Heidenreich S, Finney Rutten L, Miller-Wilson L, Jimenez-Moreno C, Chua G, Fisher D
Cancer Med . 2022 Mar; 11(16):3156-3167. PMID: 35315224
Background: Guidelines include several options for average-risk colorectal cancer (CRC) screening that vary in aspects such as invasiveness, recommended frequency, and precision. Thus, patient and provider preferences can help identify...
35.
MacLaughlin K, Jacobson R, St Sauver J, Jenkins G, Fan C, Finney Rutten L
Womens Health Rep (New Rochelle) . 2022 Feb; 3(1):10-19. PMID: 35136872
Cervical cancer screening has shifted toward human papillomavirus (HPV)-based testing, but uptake of primary HPV screening in the United States is unknown and previous studies highlight delays in clinician adoption...
36.
Schear R, Hoyos J, Davis A, Woods P, Poblete S, Richardson R, et al.
Cancer . 2022 Feb; 128 Suppl 4:909-917. PMID: 35133663
No abstract available.
37.
Zhu X, Weiser E, Jacobson D, Griffin J, Limburg P, Finney Rutten L
Prev Med Rep . 2022 Feb; 25:101681. PMID: 35127359
Background: Average-risk colorectal cancer (CRC) screening remains underutilized in the US. Provider recommendation is strongly associated with CRC screening completion. To inform interventions aimed at improving screening uptake, we examined...
38.
Chamberlain A, St Sauver J, Finney Rutten L, Fan C, Jacobson D, Wilson P, et al.
Mayo Clin Proc . 2022 Jan; 97(1):57-67. PMID: 34996566
Objective: To determine the association of socioeconomic status at the census block group level with chronic conditions and to determine whether the associations differ by age, sex, race, or ethnicity....
39.
Finney Rutten L, Parks P, Weiser E, Fan C, Jacobson D, Jenkins G, et al.
Mayo Clin Proc . 2021 Dec; 97(1):101-109. PMID: 34920895
Objective: To assess health care provider (HCP) preferences related to colorectal cancer (CRC) screening overall, and by HCP and patient characteristics. Participants And Methods: We developed a survey based on...
40.
Kurani S, MacLaughlin K, Jacobson R, St Sauver J, Jenkins G, Fan C, et al.
Vaccine . 2021 Dec; 40(3):471-476. PMID: 34916103
Importance: Despite availability of safe and effective human papillomavirus (HPV) vaccines, vaccination uptake remains low in the U.S. Research examining the impact of neighborhood socioeconomic status on HPV vaccination may...